Diaryl ether hetrocycles
AssigneesImperial Chemical Industries PLC, ICI Pharma
InventorsThomas G. C. Bird, Philip N. Edwards
Life of this patent
Estimating the term…
Loading patent…
AssigneesImperial Chemical Industries PLC, ICI Pharma
InventorsThomas G. C. Bird, Philip N. Edwards
Estimating the term…
The invention concerns a diaryl ether heterocycle of the formula I, or a pharmaceutically-acceptable salt thereof, ##STR1## wherein Ar.sup.1 is optionally substituted phenyl or naphthyl; X.sup.1 is oxy, thio, sulphinyl or sulphonyl; Ar.sup.2 is optionally substituted phenylene, or a 6-membered heterocyclene moiety containing up to three nitrogen atoms; R.sup.1 is (1-6C)alkyl, (3-6C)alkenyl, (3-6C)alkynyl, cyano-(1-4C)alkyl or (2-4C)alkanoyl, or optionally substituted benzoyl; and R.sup.2 and R.sup.3 together form a group of the formula --A.sup.2 --X.sup.2 --A.sup.3 -- wherein each of A.sup.2 and A.sup.3 is (1-4C)alkylene and X.sup.2 is oxy, thio, sulphinyl, sulphonyl or imino. The invention also concerns processes for the manufacture of a diaryl ether heterocycle of the formula I, or a pharmaceutically-acceptable salt thereof, and pharmaceutical compositions containing said heterocycle. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.
A diaryl ether heterocycle of the formula I
A diaryl ether derivative of the formula I, or a pharmaceutically-acceptable salt thereof, selected from the group consisting of:
A diaryl ether derivative of the formula I, or a pharmaceutically-acceptable salt thereof, selected from the group consisting of:
Dependencies are inferred from the claim text.